Education
About Us
Working with TipRanks
Follow Us
Heron Therapeutics (HRTX)
NASDAQ:HRTX
Htx-011, Bupivacaine Hcl, Luer-Lock Applicator, Vial Access Device
Postoperative Pain
Phase III
Completed
Bunionectomy Study for Postoperative Analgesia (EPOCH 1)
Sep 25, 2017
―
Htx-011, Bupivacaine Hcl, Luer-Lock Applicator, Vial Access Device
Postoperative Pain
Phase III
Completed
Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
Jul 31, 2017
―
Htx-011, Bupivicaine Hcl, Ropivacaine
Postoperative Pain
Phase II
Completed
Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
Jan 06, 2017
―
Htx-011, Bupivacaine Hcl Without Epinephrine
Postoperative Pain
Phase II
Completed
Phase 2B Upper Extremity Nerve Block Study
Jan 03, 2017
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Heron Therapeutics (HRTX) have in its pipeline
HRTX is currently developing the following drugs: Htx-011, Bupivacaine Hcl, Luer-Lock Applicator, Vial Access Device, Htx-011, Bupivacaine Hcl, Luer-Lock Applicator, Vial Access Device, Htx-011, Bupivicaine Hcl, Ropivacaine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.